Efficacy of cell therapy for osteonecrosis of the hip compared with hip arthroplasty in sickle cell disease: a systematic review

Author:

Botelho Valéria1,Gomes Stéfany de Lima2,Pereira Beatriz Neves da Rocha1,de Souza Andreza Maria Luzia Baldo2ORCID,Souza Lohana Guimarães3,Tamay Tamay Botelho4,Santos Roberto Dias5,Pereira Antonio Carlos6

Affiliation:

1. UFBA: Universidade Federal da Bahia

2. Universidade Estadual de Campinas Faculdade de Odontologia de Piracicaba

3. UFSB: Universidade Federal do Sul da Bahia

4. Centro Universitário Don Pedro II

5. Universidade Federal da Bahia

6. UNICAMP: Universidade Estadual de Campinas

Abstract

Abstract Objective: To evaluate the clinical efficacy and effectiveness of the use of cell therapy in the treatment of osteonecrosis of the hip in people with sickle cell disease (SCD) compared with hip arthroplasty. Methodology: Articles published from 2015 to 2019 in English, Portuguese, or Spanish were screened in the following databases: Cochrane, PubMed, Science Research, CAPES (Coordination for the Improvement of Higher Education Personnel), Virtual Health Library (VHL) and SciELO (Scientific Electronic Library Online). The following keywords were used: cell therapy, osteonecrosis, hip, sickle cell anemia and arthroplasty. People with sickle cell disease who developed osteonecrosis of the hip and underwent treatment using cell therapy or hip arthroplasty were selected as the sample. Results: After refining the searches and organizing the references, seven studies were selected that met the eligibility criteria. Discussion: We found that out of the seven studies evaluated, three presented autologous bone marrow cell implantation and four presented hip arthroplasty (THA) as an intervention procedure in osteonecrosis of the hip in people with SCD. In all studies in which THA was used, there was a higher prevalence of complications such as vaso-occlusive crises, pain, surgical wound infection and reintervention, among others. In most studies using cell therapy, pain was reduced or absent, there were no complications and reintervention was not necessary. All studies with cell therapy indicated a reduction in the progression of osteonecrosis of the hip. Conclusion:Considering the analyzed studies, it was found that autologous bone marrow cell implantation has gained prominence and great relevance in the treatment of osteonecrosis of the hip in people with sickle cell disease, presenting a better clinical outcome and greater efficacy and effectiveness compared with hip arthroplasty. Systematic review record: a study pre-registered in PROSPERO (https://www.crd.york.ac. uk/prospero/display_record.php?ID=CRD42020199505) under the number CDR42020199505, before data collection.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3